World's Best Scientists 2026 revealed!
Giorgio Parmiani

Giorgio Parmiani

Award Badge
Immunology
Italy
2023

D-Index & Metrics

Immunology

D-Index
107
Citations
41675
World Ranking
547
National Ranking
14

Medicine

D-Index
107
Citations
41661
World Ranking
6262
National Ranking
198

Research.com Recognitions

  • 2023 - Research.com Immunology in Italy Leader Award
  • 2022 - Research.com Immunology in Italy Leader Award

Overview

Giorgio Parmiani was affiliated with the University of Siena in Italy. Their research work primarily focused on the fields of Immunology and Microbiology, with additional contributions to Medicine. Within these domains, they developed a specialized focus on Immunology and Oncology as subfields of study.

The main topics explored in their research included Immunotherapy and Immune Responses, CAR-T cell therapy research, and Immune Cell Function and Interaction. These topics reflect a concentration on the mechanisms and applications of immune modulation, particularly in the context of therapeutic interventions.

Throughout their career, Giorgio Parmiani collaborated with several frequent co-authors. These included Andrea Balsari, Monica Rodolfo, and Giuseppe Fossati, indicating a network of scientific partnerships contributing to their body of work.

Best Publications

  • Phenotypic characterization of human colorectal cancer stem cells

    Piero Dalerba;Scott J. Dylla;In Kyung Park;Rui Liu

  • A listing of human tumor antigens recognized by T cells.

    Nicolina Renkvist;Chiara Castelli;Paul F. Robbins;Giorgio Parmiani

  • Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

    M Marchand;N van Baren;N van Baren;P Weynants;P Weynants;V Brichard;V Brichard;V Brichard

  • Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

    Paola Filipazzi;Roberta Valenti;Veronica Huber;Lorenzo Pilla

  • Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

    Giovanna Andreola;Licia Rivoltini;Chiara Castelli;Veronica Huber

  • Therapeutic vaccines for cancer: an overview of clinical trials

    Ignacio Melero;Gustav Gaudernack;Winald Gerritsen;Christoph Huber

  • Interleukin-12: biological properties and clinical application.

    Michele Del Vecchio;Emilio Bajetta;Stefania Canova;Michael T. Lotze

  • A listing of human tumor antigens recognized by T cells: March 2004 update

    Luisa Novellino;Chiara Castelli;Giorgio Parmiani

  • Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

    Arianna Calcinotto;Paola Filipazzi;Matteo Grioni;Manuela Iero

  • Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes

    Roberta Valenti;Veronica Huber;Paola Filipazzi;Lorenzo Pilla

  • Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape.

    Veronica Huber;Stefano Fais;Manuela Iero;Luana Lugini

  • Tumour-released exosomes and their implications in cancer immunity

    M Iero;R Valenti;V Huber;P Filipazzi

  • Tumor-Released Microvesicles as Vehicles of Immunosuppression

    Roberta Valenti;Veronica Huber;Manuela Iero;Paola Filipazzi

  • Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

    M Marchand;P Weynants;E Rankin;F Arienti

  • Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

    Giorgio Parmiani;Chiara Castelli;Piero Dalerba;Roberta Mortarini

  • Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

    Filiberto Belli;Alessandro Testori;Licia Rivoltini;Michele Maio

  • Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs

    Francesca Luciani;Massimo Spada;Angelo De Milito;Agnese Molinari

  • Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients

    Giorgio Parmiani;C. Castelli;L. Pilla;M. Santinami

  • Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo.

    M P Colombo;G Ferrari;A Stoppacciaro;M Parenza

  • LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.

    Chiara Camisaschi;Chiara Casati;Francesca Rini;Michela Perego

  • Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

    Markus J. Maeurer;Susanne M. Gollin;Dina Martin;William Swaney

Frequent Co-Authors

Licia Rivoltini
Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori
Chiara Castelli
Chiara Castelli University of Milan
Andrea Anichini
Andrea Anichini Fondazione IRCCS Istituto Nazionale dei Tumori
Mario P. Colombo
Mario P. Colombo Fondazione IRCCS Istituto Nazionale dei Tumori
Michele Maio
Michele Maio University of Siena
Carlo Gambacorti-Passerini
Carlo Gambacorti-Passerini University of Milano-Bicocca
Marco A. Pierotti
Marco A. Pierotti University of Bari Aldo Moro
Filippo Belardelli
Filippo Belardelli National Research Council (CNR)
Stefano Fais
Stefano Fais Istituto Superiore di Sanità
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare roles that offer robust opportunities for specialization and growth. For those interested in nursing as a pathway, there are several accessible degree options to consider. Many students explore easiest absn programs to get into, which provide a streamlined route to becoming a registered nurse, an essential foundation for advancing in clinical immunology.

Another entry point into healthcare with quicker admission processes is the easy admission lpn programs. Licensed Practical Nurses play a vital role in patient care and can gain valuable experience that complements immunology-related fields.

For those aiming to assume advanced clinical responsibilities, exploring what is the easiest np program may be beneficial. Nurse Practitioner programs offer specialized training, often including immunology and related health sciences.

Additionally, mental health nursing with a focus on psychiatric care can be pursued through leading programs such as the best pmhnp programs online. These programs combine clinical placements with academic rigor, broadening career pathways within immunology's intersection with neuroimmune and psychiatric disorders.

Best Scientists Citing Giorgio Parmiani

Recently Published Articles